FDA clears first blood test to reliably predict Alzheimer’s disease
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for the illness. The test is called the “Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio” and is developed by the Japanese company Fujirebio Diagnostics…
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
.png?Expires=1838763821&Key-Pair-Id=K2ZIVPTIP2VGHC&Signature=IO0~CT3pU-TcxGc~yoZSmoQx23MZVuK-~4jSii~NKEblRmyO3el7NXPu~Rh1o23voASg7hlcHLw4kvQuDK1jssEhcjoNBBvEpZ~GGOAU6yosBhpHpeF179F~h7i6VxmsBNh9gtTutkoqY73O2YCFey~IAqSzKbBqETP1kP9cAg1916Z1YkJJs-5MliMrkZ5d7-mWGLbpHp2wGj2VlMph8XzYlL4~y1O7fB~JdIS~Rs4RMRs2x0WT1qUIpHAsf3GdwtOyAmKFSpIg8xCyNGZZ5h~13nXlmpd7uPvW8tBfttpG9pFTqcway-uch5WyfHOEfi7UlJCOWrr6fCYY5PMgSg__)
